Bexgliflozin (EGT1442)
Bexagliflozin is a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor with IC₅₀ values of 5.6 µM and 2 nM for human SGLT1 and SGLT2, respectively. Bexagliflozin dose-dependently reduces HbA(1c) and blood glucose concentration without affecting body mass or insulin level.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog